What do U.S. biopharmaceutical companies get from patents and research and development spikes for their dynamic corporate performance?
Date
2020-07-01
Journal Title
Journal ISSN
Volume Title
Publisher
John Wiley and Sons Ltd
Abstract
Description
item.page.type
Article
item.page.format
Keywords
Intellectual Property-Rights, Market Value, Operating Performance, Contextual Variables, Firm Value, Innovation, Efficiency, Productivity, Investment, Impact
Citation
Wang, W., Lu, W., Kweh, Q. L., & Truong, H. T. N. (2020). What do U.S. biopharmaceutical companies get from patents and research and development spikes for their dynamic corporate performance?. Managerial and Decision Economics, 41(5), 762-770. https://doi.org/10.1002/mde.3135